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ABSTRACT
Genetic polymorphisms are variations found in DNA sequences 
and they are integral to the development of genetic markers to 
identify individuals at risk and it requires certain techniques and 
strategies to detect the mutations. Most of the variations found 
in DNA sequences are stable and occur in the form of single 
nucleotide polymorphism (SNPs), insertion/deletion (I/D) and 
variable tandem repeats. Among the genetic polymorphisms, SNPs 
are the most abundant form in the human genome, accounting for 
more than 90% of all differences among individuals. Variation 
occurs when a single nucleotide (A, T, C, or G) alters in the 
genome sequence. SNPs are stable, di-allelic and the two alleles 
represent the “wild-type” and the “mutant type” forms. SNPs are 
frequently studied in relation to various cancers for their known 
biochemical or physiological function. Several studies have been 
done in understanding the possible role of genetic variation in the 
human genome. Identifying the association between the ancestral 
variants in genes are common in polygenic diseases which become 
increasingly reasonable with improved methods for detecting 
genetic variants on a genome-wide scale. Over the years, several 
researches have been conducted to detect the cause of various 
genetic disorders. Genetic polymorphisms play an important 
role in human health especially in the development of essential 
hypertension and type 2 diabetes mellitus. Our genetic research 
group works toward understanding the interaction between genes 
and environmental exposures in various human diseases such as 
congenital heart disease, hypertension, metabolic syndrome, end 
stage renal disease, prostate cancer, polycystic kidney disease etc. 
Our group research has two main elements: investigating the role 
of environmental exposure in critical target gene mutation and the 
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role of genetic susceptibility and environmental exposure in those 
disorders. In addition, more fundamental researches are going 
on in order to know the genetic and allelic frequency of certain 
susceptibility genes for the development of various disorders.
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INTRODUCTION
Genetic Polymorphism 
Genetic polymorphism is defined as the inheritance of a trait 
controlled by a single genetic locus with two alleles, in which 
the least common allele has a frequency of about 1% or greater 
whereas the term mutation is usually reserved for DNA sequence 
variants that cause diseases and are present in the population at a 
frequency of less than 1% (Gelehrler and Collins, 1990). Genetic 
polymorphisms are different forms of DNA sequence. “Poly” 
means many, and “morph” means form. Polymorphisms are a type 
of genetic diversity within a population’s gene pool. 
 DNA sequences are different among individuals in groups and 
populations. Most of the variations found in DNA sequence are 
stable and occur in the form of single nucleotide polymorphism 
(SNPs), insertion/deletion (I/D) and variable tandem repeats. SNPs 
are stable, they are di-allelic, the two alleles represent the “wild-
type” and the “mutant type” forms (Doris et al., 2002). Variation 
occurs when a single nucleotide (A, T, C, or G) alters in the genome 
sequence. Common sequence variants occur in about 1 in every 
1000 bases of coding/ regulatory sequence. In every gene there is an 
average of 4-8 SNPs occurring either in the exons or coding regions 
or in the nearby exons and introns boundaries in the upstream 
regulatory regions. Each person would be heterozygous for 24,000-
40,000 non-synonymous (amino acid altering) substitutions (Lele 
et al., 2003). 
How Do Mutations Occur? 
Genetic polymorphisms may be the result of chance processes, 
or may have been induced by external agents that could be such 
as viruses or radiation causes. If there are differences in DNA 
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sequence among individuals, it has been shown to be associated 
with diseases and it is usually called a genetic mutation. Changes 
in DNA sequence which have been confirmed to be caused by 
external agents are also generally called “mutations” rather than 
“polymorphisms” (Smith, 2002).
 Mutation can occur when there is a mistake which can be 
called copying errors when DNA replicates itself. Other changes 
are introduced as a result of DNA damage which is due to 
environmental agents including sunlight, cigarette smoke and 
radiation in which these mutations are not passed on to children. 
Germline mutation, which can be passed from a parent to a child 
when a mutation occurs in the DNA of cells that produce eggs and 
sperms and every cell in their body, will have this error in their 
DNA and cause diseases to run in families, and are responsible for 
the hereditary diseases.
Types of  Mutations
Human DNA polymorphisms can be split into two groups: single 
nucleotide polymorphisms and insertion/ deletion (INDELS) of 
one or more nucleotides.  Insertion/Deletion can be further divided 
into those with multiple alleles (multiallelic) and those with only 
two alleles (diallelic). Nearly all of the multiallelic indels are based 
on tandem repeats, mostly short tandem repeats. More recently, 
millions of SNPs candidates have been identified and are beginning 
to apply (Sachidanandam et al., 2001)
Single Base Substitutions 
A SNP (“snip”) is a single base mutation in DNA and it is a source 
variance in a genome. SNPs are the most simple form and most 
common source of genetic polymorphism in the human genome 
(90% of all human DNA polymorphisms).
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There are two types of nucleotide base substitutions resulting in 
SNPs. 
1.  A transition substitution occurs between purines (A, G) or 
between pyrimidines (C, T). This type of substitution constitutes 
two thirds of all SNPs. 
2.  A transversion substitution occurs between a purine and a 
pyrimidine.
Mis-sense Mutations 
Mis-sense mutation is a point mutation in which a single nucleotide 
is changed which results in a codon that codes for a different 
amino acid. For example in sickle cell anaemia the 17th nucleotide 
of the gene for the beta chain of haemoglobin is changed from ‘A’ 
to ‘T’. This changes the codon from ‘GAG’ to ‘GTG’ resulting in 
the 6th amino acid of the chain being changed from glutamic acid 
to valine (Figure 1). This apparently trivial alteration to the beta 
globin gene alters the quaternary structure of haemoglobin, which 
has a profound influence on the physiology and well being of an 
individual. 
                  Thr     Pro    Glu     Glu
   Normal      ACT  CCT  GAG  GAG
     Mutated    ACT  CCT   GTG   GAG
                    Thr     Pro    Val     Glu
Figure 1  An example of mis-sense mutation in which a substitution of 
‘A’ in the second codon to a ‘G’ leads to an amino acid substitution of 
Glutamine to Valine.
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Nonsense Mutations 
In a nonsense mutation, the new base changes a codon that specified 
an amino acid into one of the STOP codons (TAA, TAG, TGA). 
This will cause translation of the mRNA to stop prematurely and 
a truncated protein to be produced (Figure 2). This truncated 
protein will not function correctly. Nonsense mutations occur in 
between 15% to 30% of all inherited diseases including cystic 
fibrosis, haemophilia, retinitis pigmentosa and duchenne muscular 
dystrophy. 
    
                His
 Normal      CAG
 Mutated    TAG
                         Gln    STOP codon
Figure 2  An example of nonsense mutation (Histidine to Glutamine) 
which can occur in Cystic fibrosis patients.
Silent Mutations 
Silent mutations are mutations that will not change the final protein 
product and can only be detected by sequencing the gene. Most 
amino acids that make up a protein are encoded by several different 
codons  As an  example, the third base in the ‘CAG’ codon is 
changed to an ‘A’ to give ‘CAA’, which is a glutamine which would 
still be incorporated into the protein product. This is because the 
mutated codon still codes for the same amino acid. These types of 
mutations are ‘silent’ and have no detrimental effect.
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Frameshift Mutations
A frameshift mutation is caused by insertions or deletions of a 
number of nucleotides that is not evenly divisible by three from 
a DNA sequence. This mutation in general causes the reading of 
the codons to code for different amino acids, but there may be 
exceptions resulting from the redundancy in the genetic code. If the 
stop codon (“UAA”, “UGA” or “UAG”) in the original sequence 
would not be read, then a stop codon could result at an earlier or 
later site (Figure 3). Thus the protein resulting from this could either 
be abnormally short or abnormally long, and will most likely not 
be functional. 
           
  Normal  AUG  AAG  UUU  GGC  GCA  UUG  GAA
    Frameshift   AUG  AAG  UUG  GCG  CAU  UGG  AA…
Figure 3  Deletion of U occurs in Tay-Sachs disease.
Single Nucleotide Polymorphisms  
Single nucleotide polymorphisms are the most common type of 
genetic variation among people. Findings from the Human Genome 
Project show that the DNA of any two people is more than 99.9 
percent identical, but 0.1 percent accounts for all the genetic 
differences among people. In literal terms, that means that one 
person might have blue eyes rather than green, or a susceptibility to 
lung cancer, or perfect pitch, because the sequence of their DNA - a 
long chain of adenine (A), guanine (G), cytosine (C) and thymine 
(T) molecules – differs from another person. Rather than having an 
A-T pair of molecules at a certain spot on the DNA chain, a person 
might have a G-C pair. On the other hand, that difference might 
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not have any effect at all on a person’s health or appearance. SNPs 
in humans are unknown, but there are probably between 10 and 30 
million SNPs, about one every 100 to 300 bases. Of these SNPs, 
perhaps four million are common SNPs, with both alleles of each 
SNP having a frequency above 20 percent. Most SNPs have no effect 
on health or development, but some of these genetic differences 
have proven to be very important in the study of human health. 
 Polymorphisms usually affect on gene structure, function and 
regulation and can identify the individuals who are predisposed 
to disease (Collins et al., 1997). The functional polymorphisms 
affect gene regulation or protein sequence whereas non-functional 
polymorphisms do not. Some SNP alleles are the actual functional 
variants that contribute to the risk of getting a disease (Ralston et al., 
2002). Individuals with such a SNP allele have a higher risk for that 
disease than do individuals without that SNP allele. Most SNPs are 
not these functional variants, but are useful as markers for finding 
them. To find the regions with genes that contribute to a disease, 
the frequencies of many SNP alleles are compared in individuals 
with and without the disease. SNP alleles in a particular region are 
more frequent in individuals with the disease than in individuals 
without the disease, those SNPs and their alleles are associated 
with the disease. These associations between a SNP and a disease 
indicate that there may be genes in that region that contribute to 
the disease.
 For most SNPs, any population has individuals of all possible 
genotypes for a SNP, but populations differ in the frequencies of 
individuals with each of the different genotype. About 85 percent 
of human SNPs variation are within all populations, and about 
15 percent are among populations. Thus two random individuals 
within a village are almost as different in their SNP alleles as any 
two random individuals from anywhere in the world. Although a 
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small proportion of SNPs have alleles that are common in some 
groups but rare in others, most SNP alleles that are common in 
one group will be common in other groups. Under the Common-
Disease/Common-Variant theory, common variants that contribute 
to a disease in one group will also contribute to the disease in other 
groups, although the amount of the contribution may vary (http//.
www.genome.gov, Haplotype Map Development Report).
RISK FACTORS
Essential hypertension (EHT) and Type 2 Diabetes Mellitus 
(T2DM) are the two most common polygenic complex disorders 
caused from interaction of several genes with each other and with 
other factors such as obesity, dietary salt intake, smoking and 
alcohol consumption.  Framingham study reported the prevalence 
of hypertension increases significantly with age and the age-
related rise in blood pressure and it was observed consistently in 
most populations (Ihab et al., 2001). People at age 35 and older 
are at risk of developing hypertension. But the prevalence of 
hypertension increases to 10.7% and exceeds 45% in those over 
60 years of age. This may be due to an exposure to environmental 
factors and lifestyle. The normal age-related rise in blood pressure 
is exaggerated in population with T2DM which may be due to 
premature vascular aging or vascular inflammation leading to 
increase arterial stiffening. 
 Diabetes tends to run in families. A person with a family history 
of diabetes is 2-4 times as likely to develop diabetes as someone 
without a family history. Familial and genetic factors may also play 
an important role in the determination of some major risk factors, 
especially hypertension, lipid abnormalities and glucose intolerance. 
The genetic link for T2DM is stronger than the genetic link for type 
1. Having a blood relative with T2DM increases the risk in both 
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men and women. Experimental models of genetic hypertension 
have shown that the inherited tendency to hypertension resides 
primarily in the kidney. For example, animal and human studies 
show that a transplanted kidney from a hypertensive donor raises 
the blood pressure and increases the need for antihypertensive drugs 
in recipients coming from “normotensive” families. Conversely a 
kidney from a normotensive donor does not raise the blood pressure 
in the recipient.
 Cigarette smoking is another major risk factor for developing 
hypertension. Cigarette smoking can repeatedly produce a transient 
rise in BP of approximately 5 to 10 mmHg (Freestone et al., 1982). 
Habitual smokers generally have lower blood pressures than non-
smokers as observed in most (Mikkelsen et al., 1997) but not all 
studies (Primatesta et al., 2001). Smoking in any hypertensive 
patient markedly increases the risk of secondary cardiovascular 
complications and appears to enhance the progression of renal 
insufficiency (Regalado et al., 2000). 
 The incidence and mortality of coronary heart disease (CHD) is 
twice as high in male cigarette smokers compared to non-smokers 
(Fodor and Tzerovska, 2004). The risk of developing CHD is 
directly related to the number of cigarettes smoked. Individuals 
who discontinue smoking may reduce this risk within a year or 
two, although it still remains slightly higher compared to non-
smokers. Even though dietary habits can have a direct effect on 
blood pressure, lifestyle choices such as alcohol intake, cigarette 
smoking, physical activity, and obesity can profoundly impact blood 
pressure regulation (Tam et al.,2005).
 When a person smokes, the body resists insulin and there is 
an increase in glucose level lead to diabetes. Adding smoking to 
diabetes drastically raises the risk of other diabetic complications. 
Smoking is also related to the premature development of 
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microvascular complications of diabetes and may even have a role in 
the development of T2DM (Haire-Joshu et al., 1999).  Kawakami et 
al, (1997), examined the effects of smoking on the 8-year incidence 
of T2DM on 2,312 Japanese men and concluded that age of smoking 
initiation and number of cigarettes smoked are major risk factors 
for developing diabetes. In another study, the effects of cigarette 
smoking are evaluated on insulin sensitivity of 40 patients with 
T2DM and found that insulin resistance is markedly aggravated 
among those who smoked (Targher et al., 1997).
Obesity
The prevalence of obesity is rapidly increasing in developing as 
well as in industrialised countries resulting in a prohibitive health 
and economic burden on society (Hall et al., 2002). Dietary intake 
and physical activity are important contributing factors in the 
development of obesity. If calorie intake is in excess of requirement 
and is not utilised overtime,   it will be stored mainly as body fat and 
later it will lead to overweight or obesity.  Obesity people are more 
likely to develop high blood pressure than others. The relationship 
between obesity and blood pressure appears to be linear and exists 
throughout the non-obese range. But the strength of the association 
of obesity with hypertension varies among different racial and ethnic 
groups (Shai et al., 2006). The overall scheme for the mechanism 
of obesity which can cause several disorders is shown in Figure 4.
❚❘❘ 12
Does Genetic Polymorphisms Affect Health?
F
ig
ur
e 
4 
 O
ve
ra
ll
 s
ch
em
e 
fo
r 
th
e 
m
ec
ha
ni
sm
s 
by
 w
hi
ch
 o
be
si
ty
, i
f 
pr
ed
om
in
an
tly
 u
pp
er
 b
od
y 
or
 v
is
ce
ra
l i
n 
lo
ca
ti
on
, 
co
ul
d 
pr
om
ot
e 
di
ab
et
es
, d
ys
li
pi
da
em
ia
 a
nd
 h
yp
er
te
ns
io
n 
vi
a 
hy
pe
ri
ns
ul
in
ae
m
ia
 
(A
da
pt
ed
 f
ro
m
 V
ik
ra
nt
 a
nd
 T
iw
ar
y,
 2
00
1)
. 
13 ❘❘❚ 
Patimah Ismail
 Body weight of an individual is usually determined by an 
interaction between genetic, environmental and psychosocial 
factors acting through the physiological mediators of energy intake 
and expenditure. A strong positive correlation between body mass 
index and blood pressure has been noted consistently in cross-
sectional and longitudinal studies (Calderon et al., 2005). Obese 
individuals have higher cardiac output, stroke volume, and central 
and total blood volume and lower peripheral resistance than non-
obese individuals with similar blood pressure (Oren et al., 1996). 
Increased body mass index (BMI) and/or waist/hip ratio (WHR) 
increases the risk of hypertension, and it has been found that waist 
circumference (WC) is positively associated with high blood 
pressure (Feldstein et al., 2005).  
 Adolescent obesity is also associated with the insulin resistance 
syndrome which includes hypertension and T2DM. Obesity is 
thought to be susceptible to type-2 diabetes primarily by causing 
insulin resistance (Dewan et al., 2003). Insulin resistance places 
a greater demand on the pancreatic capacity to produce insulin, 
which also declines with age, leading to the development of clinical 
diabetes. Physical inactivity, both a cause and consequence of 
weight gain, also contributes to insulin resistance.
 Obesity is a major underlying cause of metabolic syndrome 
which includes abdominal obesity, hypertension, insulin resistance 
with or without glucose intolerance, or diabetes (Sarti & Gallagher, 
2006). The RAAS seems to be activated in obesity, despite a 
state of volume expansion and sodium retention. Elevated serum 
aldosterone levels have been reported in the obese (Engeli et al., 
2002) and it is postulated by a fatty acid derived from adipose 
tissue causes the release of a hepatic factor that, in turn, steps up 
aldosterone synthesis (Goodfriend et al.,1999).
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Cholesterol
Cholesterol is a fat-like substance presents in cell membranes that 
circulates in the blood and it is a precursor of bile acids and steroid 
hormones. Cholesterol travels in the blood in distinct particles 
containing both lipid and proteins (lipoproteins). It circulates 
through Low Density Lipoprotein (LDL) and High Density 
Lipoprotein (HDL). Hypertension and hypercholesterimia (high 
intake of dietary fats) often co-exist as risk to CHD. Several studies 
have reported the relation between blood pressure and cholesterol 
level (Lewington and Clarke, 2005). More than 40 percent of people 
with diabetes have abnormal levels of cholesterol and similar fatty 
substances that circulate in the blood. These abnormalities appear 
to be associated with an increased risk of cardiovascular disease 
among persons with diabetes. The strong association between 
hyperlipidemia, hypertension and T2DM lead to an extensive list 
of long-term complications, including a high rate of cardiovascular 
death and even amputation due to accelerated atherosclerosis, and 
also the typical complications of diabetes such as retinopathy, 
nephropathy, and neuropathy (Khan et al., 1996). 
 Low-density lipoprotein accounts for the majority of cholesterol 
in the blood. It is sometimes referred to as “bad” cholesterol because 
it can build up in the arteries and cause heart disease and stroke.  On 
the other hand High-density lipoprotein help to remove cholesterol 
from the body and referred to as “good” Cholesterol.  Higher levels 
of HDL more than 60mg/dl are better in which it can protect the 
heart disease. 
 Triglycerides are a type of fat in which majority of them are 
circulating in the blood. They are carried throughout the body 
by a special lipoprotein called a chylomicron. Triglycerides can 
come from the fat we eat, or fat which is made in the body from 
carbohydrates. Too many triglycerides in the blood are called 
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hypertriglyceridemia, which is a risk factor for cardiovascular 
disease (heart disease). People on low carbohydrate diets rarely have 
triglycerides above normal (150 mg/dL). High triglyceride levels 
are associated with low HDL, obesity, diabetes and high pressure 
(Fruchart et al., 2005). The presence of increased triglycerides 
and decreased HDL levels are the best predictor of cardiovascular 
disease in patients with T2DM (Laakso et al., 1993). Plasma 
triglyceride level is frequently increased in T2DM, mainly due 
to an increased number of VLDL particles (Howard et al., 1995). 
In type 2 diabetic patients, the major features of dyslipidemia are 
increased triglyceride levels, decreased HDL-C levels, and changes 
in the composition and level of LDL-C (Hobbs et al., 2006). 
Epidemiologic data indicate that risk factors for coronary disease 
in T2DM include elevated LDL-C levels, HDL-C levels, elevated 
blood pressure, hyperglycaemia and cigarette smoking (Turner et 
al., 1998). Although concentrations of total and LDL cholesterol 
in diabetic individuals are reportedly comparable with levels 
found in people without diabetes, low levels of HDL cholesterol 
and elevated triglyceride levels, both are probable contributors to 
cardiovascular diseases (CVD) (Laakso et al., 1996). The prevalence 
of these abnormalities appears to be approximately twice as high 
as in patients with T2DM. 
Serum Electrolytes
Serum electrolytes such as sodium, potassium and chloride play a 
central role in the normal regulation of blood pressure (Giasuddin 
et al., 1991). Especially sodium and potassium regulate the fluid 
balance of the body and influence the cardiac output. Several studies 
suggested that the present levels of intake of mineral elements are 
not optimum for maintaining normal blood pressure but predispose 
to the development of hypertension.    
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 Sodium plays a central role in many physiologic functions 
including the regulation of intravascular and extravascular volume 
status and blood pressure levels (Ajani et al., 2005). Sodium 
retention occurs as a characteristic alteration in Type I or Type 
II diabetes; exchangeable body Na+ is increased by 10% on 
average. This abnormality develops in the uncomplicated stage 
of diabetes and differentiates diabetic from non-diabetic essential 
hypertensive subjects. The pathogenetic role of sodium retention 
in diabetes-associated hypertension is supported by positive 
correlations between systolic or mean blood pressure and Naex 
and by normalisation of blood pressure after removal of excess 
sodium by diuretic treatment in hypertensive diabetic subjects. The 
latter may also have an enhanced sensitivity of blood pressure to 
sodium. Plasma levels of active renin, angiotensin II, aldosterone, 
and catecholamine are usually normal or low in metabolically 
stable type I or type II diabetes. However, an exaggerated vascular 
reactivity to nor epinephrine and angiotensin II commonly occurs 
already at uncomplicated stages of Type I or Type II diabetes. 
This may be a manifestation of functional (i.e., intracellular 
electrolytes) and/or morphological (proliferation, narrowing, and 
stiffening) vasculopathy. Diabetes-associated sodium retention, 
vasculopathy, and a presumably inherited predisposition for both 
diabetes and EHT may represent important complementary factors 
favoring the frequent occurrence of hypertension in the diabetic 
population (Weidmann and Ferrari, 1993). In a large prospective 
study of nutritional factors and development of hypertension 
among American men, a low potassium intake is a predictor for 
the development of hypertension with a relative risk of 1.54 for 
subjects in the lowest quintile of potassium intake (Acherio et al., 
1992).
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Genetic Factors
Hypertension is an important public health challenge worldwide 
because of its prevalence and its role as a risk factor for 
cardiovascular disease.  Hypertension is a complex genetic disorder 
caused by interplay between several ‘risk’ genes and environmental 
factors. Genetic elements contribute to 30–50% of the blood 
pressure variability in human essential hypertension (Garcia et 
al., 2003). In 2005, Kearney et al. reported that an estimated total 
number of adults with hypertension in 2000 was 972 million. Of 
these, 333 million were estimated to be in economically developed 
countries and 639 million in economically developing countries. 
By 2025, the number of people with hypertension will increase 
by about 60% to a total of 1.56 billion as the proportion of elderly 
people will increase significantly. Other reasons are the continuing 
population increase and changes in lifestyle, which include a diet 
rich in sugar and high-fat processed foods and sedentary behavior, 
mediated by television, computers and cars. Since the proportion 
of hypertensive people will increase dramatically worldwide, the 
prevention, detection, treatment and control of this condition should 
be a top priority.
 Hypertension is about twice as common in subjects who have 
one or two hypertensive parents. Many epidemiological studies 
suggested that genetic factors account for approximately 30% of 
the variation in blood pressure in various populations (Izawa et 
al., 2003). Although separate genes and genetic factors have been 
linked to the development of EHT, multiple genes are most likely to 
contribute the development of the disorder in a particular individual 
(Figure 5). The role of these genes is extremely difficult to determine 
the relative contribution to the disease. It has been well supported 
from comparisons of parents with their monozygotic and dizygotic 
twin studies (Koskenvuo et al., 1992). 
❚❘❘ 18
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 By acquiring detailed knowledge about an individual’s genetic 
background, through the analysis of polymorphisms and their 
impact on gene expression and protein levels, as well as the 
influence of environmental exposure, a big step is taken towards 
an early prediction of a patient’s clinical outcome, thereby making 
it possible to identify ‘high-risk patients’ at an early stage of the 
disease. However, the mechanisms that resulted in a specific 
phenotype are complex and represent a great challenge for clinicians 
and researchers, considering the great number of existing both 
known and unknown gene-gene and gene-environment interactions. 
The genetic and clinical data collected may be used for several 
applications, such as early risk factor stratification, for prediction 
of response to a specific treatment, in pharmacogenetics and 
pharmacogenomics, for the selection of participants in clinical 
trials and finally as a basic research tool (Nordfors et al., 2005)
 The identification of genetic variants that contribute to the 
development of hypertension is complicated, for example cardiac 
output and total peripheral resistance phenotypes determine the 
development of hypertension but also controlled by intermediary 
phenotypes, including the autonomic nervous system, vasopressor/
vasodepressor hormones, the structure of the cardiovascular system, 
body fluid volume and renal function, and many others. Moreover, 
these intermediary phenotypes are also controlled by complex 
mechanisms including blood pressure itself (Williams et al., 1994). 
Thus there are many genes that could participate in the development 
of hypertension. Genetic factors also influence behavioral patterns, 
which might lead to BP elevation. Tendencies towards obesity 
or alcoholism are influenced by both genetic and environmental 
factors; thus the proportion of blood pressure variability caused 
by inheritance is difficult to determine and may vary in different 
populations (Adamo and Tesson, 2008).
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 Genes play an important role in the development of T2DM. 
T2DM is a polygenic disorder with multiple genes located on 
different chromosomes contributing to its susceptibility. Analysis 
of a particular genetic factor is further complicated by numerous 
environmental factors interrelated with genes to influence the 
disorder.
 The prevalence of T2DM varies widely among different 
populations. Part of the observed ethnic variability can be attributed 
to non genetic environmental factors; however, the fact that the 
prevalence of the disease varies substantially among ethnic groups 
that share a similar environment suggests that genetic factors also 
contribute to predisposition to the disease (Diamond, 2003). Another 
source of evidence for genetic contribution to the disease is familial 
aggregation also share common environmental traits. The odd ratio 
for offspring of a single affected parent is 3.5 and 6.1 if both parents 
are affected compared to those with no parental diabetes history 
(Meigs et al., 2000). The report from several studies supported a 
genetic basis for measures of both insulin sensitivity and insulin 
secretion (Gerich et al., 1998). 
 Understanding the genetic variation that contributes to the 
pathogenesis of T2DM will require the use of a wide variety of 
in vitro and in vivo tools for functional analysis. Understanding 
the contribution of genetic variation to disease within populations 
will require a simultaneous acquisition of detailed genetic and 
environmental (life-style) data from very large population cohorts 
and case-control studies.
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GENETIC POLYMORPHIC STUDIES 
Study Strategies 
There are two main strategies for identifying genes involved 
in human disease. In monogenic disorders linkage analysis is 
performed using panels of genetic markers (i.e. microsatellite 
markers) to identify a particular locus that co-segregates with 
disease in affected families. However in multifactorial disorders, 
where a phenotype depends on complex interactions between 
several genes, as well as with environmental factors, it is more 
difficult to identify a particular gene variant contributing to a 
specific phenotypic trait. In this case, the most common approach 
is the association studies using sets of SNPs in candidate genes 
for genotyping of clinically well-characterised patient materials, 
which need to be large enough to detect also small effects of SNPs. 
A critical step in such association studies is to identify candidate 
genes for investigation. In contrast to linkage studies, candidate 
gene association studies therefore require previous understanding 
of the pathophysiologic pathways involved in a particular trait.
 Basic research strategies that may be applied in studies of patients 
with end-stage renal disease are;
•	 Linkage studies in families
•	 Monogenic disorders
•	 Microsatellite markers
•	 Association studies in populations
•	 Polygenic disorders
•	 Well-characterised clinical material
•	 High throughput SNP-analysis
•	 Microarray technology (DNA chips)
•	 Hypothesis generation
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 The genetic polymorphisms are integral to the development of 
genetic markers to identify the individuals at risk of developing 
the diseases. To identify the common disease susceptibility loci, 
many studies encompassing genome-wide association mapping, 
linkage (Krushkal et al., 1999), candidate gene association (Yamada 
et al., 2002) have been utilised.  It has been realised that genetic 
susceptibility to the common complex disorders probably involves 
many genes, most of which have small effects (Cordell and Clayton, 
2005)
Candidate Gene Approach
The search for susceptibility genes in predisposes to hypertension 
and T2DM centers on two major techniques, linkage mapping 
and the candidate gene approach. Linkage mapping also known 
as positional cloning, is the process of systematically scanning 
the entire genome of various members of families affected by 
the disorder using regularly spaced, genetic variation those exact 
position is known (i.e., genetic markers). Using those families, the 
genetic regions associated or “in linkage” with the disease can be 
identified by observing that affected family members which share 
certain alleles located in those regions more frequently than would 
be expected by chance. These regions can then be isolated, or 
cloned, for further analysis and characterization of the responsible 
genes. Linkage mapping techniques have already resulted in the 
identification of several potential DNA regions that may contain 
susceptibility genes for hypertension (Caulfield et al., 2003) and 
T2DM (Huang et al., 2006). The primary advantage of linkage 
mapping is that investigators need no prior knowledge of the 
physiology or biology underlying the disorder being studied, which 
is important for complex disorders. Whereas the linkage mapping 
approach is an unbiased search of the entire genome without any 
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preconceptions about the role of a certain gene, the candidate 
gene approach allows researchers to investigate the validity of an 
“educated guess” about the genetic basis of a disorder. 
 The candidate gene approach involves assessing the association 
between a particular allele or a set of alleles of a gene that may 
be involved in the disease. In other words, this type of association 
study tries to answer the question, “Is one allele of a candidate gene 
more frequently seen in subjects with the disease than in subjects 
without the disease?” The candidate genes are selected on the basis 
of known biochemical or physiologic components related to disease 
(Kohara et al., 2008). In contrast with linkage mapping studies, 
however, studies of candidate genes do not require large families 
with both affected and unaffected members, but can be performed 
with unrelated cases and control subjects or with small families. 
Moreover, candidate gene studies are better suited for detecting 
genes underlying common and more complex diseases where the 
risk associated with any given candidate gene is relatively small 
(Kwon et al.,2000, Collins et al.,1997).
Case-Control Study
Genetic studies can be categorised into candidate gene approaches 
and genome-wide screens. Association studies are adequate for 
testing candidate genes, or narrowing down to a particular gene 
once a region of linkage has been detected. The association or 
case-control study tests the different allele or genotype frequencies 
between the case and control populations which allow the use of 
large set of unrelated individuals using this paradigm rather than 
using a pedigree-based linkage analysis. In general, a case-control 
study has greater statistical power than a linkage analysis, but it is 
also more liable to show false positive results. 
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 This strategy is to search for the association between one or 
more markers within the critical interval and the disease under 
investigation. This is based on the concept that the susceptibility 
allele is more prevalent in the Hypertensive, T2DM group or any 
other disease, than in the controls (Lander and Schork, 1994). In 
recent years the population based case–control studies of unrelated 
individuals earned the status of gold standard in the search for the 
association of the sequence differences with complex diseases. 
The important advantage is a large analytical power and the 
disadvantages are frequent results of borderline significance and 
lack of confirmatory reports from other populations or ethnic groups 
(Ardile et al., 2002; Morton and Collins, 1998). These studies have 
greater power to detect the effects of common variants (Risch & 
Merikangas, 1996). 
 Control subjects are a valid comparison group for these 
association studies, though it could not be predicted whether some of 
them would develop various diseases in future. Statistical evidence 
for an association between an allele and a phenotype comes from 
one of three situations. (i) The allele itself might be functional and 
directly affect expression of the phenotype. (ii) The allele might be 
correlated with, or be in linkage disequilibrium with, a causative 
allele located nearby. (iii) The association could be attributable to 
chance, artifact, or selection bias (Agarwal et al., 2005). Usually, 
association studies are performed using a case-control cohort 
format with all the difficulties of ensuring that the controls are 
true controls (Cardon et al., 2003). Population stratification 
(namely the separation of a study population into subgroups) is 
often a confounding factor. Association and linkage studies are 
complementary methods that, together, provide the means to probe 
the genome and describe the genetic etiology of complex human 
traits, potentially elucidating the mechanism leading to some of 
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the most important contemporary health problems (Williams et al., 
1997).
 Some questions to be answered when reading a research paper on 
association between DNA polymorphisms and phenotype (Adapted 
from Nordfors et al., 2005); 
•	 Is the material large enough (i.e >200-300 patients ) to be 
sufficiently powered
•	 Have controls been evaluated?
•	 Have the positions of SNPs been clearly defined?
•	 Are data about Hardy-Weinberg calculations presented and are 
the criteria fulfilled in controls?
•	 Has linkage disequilibrium among different SNPs on the same 
chromosome been evaluated?
•	 If the material has sufficient power – has a haplotype analysis 
been performed?
•	 Has the protein products been analysed?
•	 Does the SNP affect transcription of the gene or protein 
expression?
•	 Has a multiple regression analysis been performed accounting 
for the impact of age, race, gender and co-morbidity?
•	 Are the results confirming the results in other patient groups?
Cross Sectional Study
A cross-sectional study is an observational study in which disease 
and exposure status is measured simultaneously in a given 
population (Kelsey, 1996). It is also called as ‘Synchronic study’ 
which provide a snapshot of the frequencies and characteristics 
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of exposure/disease in a population at a particular point in time 
and, as a result, valuable insights for delineating the multi-step 
association between exposure and disease occurrence (Kang et al., 
2005). This strategy is to search for the association between one 
or more markers within the critical interval and the disease under 
investigation. This is based on the concept that the susceptibility 
allele is more prevalent in EHT, T2DM group or any other disease, 
than in the controls (Lander and Schork, 1994). The cross-sectional 
studies take place at a single point in time and cannot identify 
cause-and-effect relationships, though they do identify the existence 
of health problems. The cross-sectional studies are considered to 
be “hypothesis generating”, such that clues to exposure/disease 
relationships can often be seen than case-control, cohort studies 
(Kelsey, 1996)
CANDIDATE GENES OF HYPERTENSION AND TYPE 2 
DIABETES MELLITUS
Several studies have been suggested that, several genes were 
hypothesised to be involved in both EHT and T2DM.  Some of the 
candidate genes showed no consistent definition for hypertension, 
other than those used clinically and also there are no differences 
between the ratios of positive to negative studies whether a rigorous 
or loose definition is used. Moreover there is no gene consistently 
associated with or linked to EHT and T2DM (Agarwal et al., 2005, 
Radha et al., 2007; Van Ittersum et al., 2000).
 The screening of candidate genes for nucleotide variants that 
are associated with EHT and T2DM is a core component of much 
diabetes and hypertension genetics research. Historically, several 
studies of the genetics of EHT and T2DM have analysed to select 
the candidate genes because of known or presumed biological 
function, with an understandable focus on the biochemical 
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pathways. The choice of candidates are inevitably limited by our 
incomplete understanding of the regulation of the processes and 
the pathophysiology of EHT and T2DM. 
Genetic Polymorphisms in Hypertension
The World Health Organization (WHO) definition of High blood 
pressure or hypertension is a systolic blood pressure ≥160 mmHg 
and/or diastolic blood pressure≥ 95mmHg. Hypertension is a 
major chronic disease in the world and it is present in 20-30% of 
adult population. Essential hypertension which is a heterogeneous 
disorder, with different patients having different causal factors 
that lead to high BP, account for 98% of hypertensive patients, 
whereas  secondary hypertension is due to underlying diseases such 
as renal artery disease, adrenal hormone excess or drugs  (Beevers 
and MacGregor., 1999). It has been approximated that there are 
nearly 972 million people with hypertension world-wide (Vasan, 
2009).  Epidemiological studies demonstrated that hypertension 
is a great risk of cardiovascular diseases such as stroke and heart 
attack. (kannel, 2004). The environmental factors that contribute 
to the development of hypertension include smoking, alcohol 
consumption, salt intake and inactivity.
 
Polymorphisms of  Renin Angiotensin-Aldosterone System 
Renin Angiotensin-Aldosterone System (RAAS) is familiarly 
involved in the regulation of blood pressure; a genetic variability 
in the degree of expression of one of its enzymes may account 
for variability in the blood pressure or may play a role in elevated 
high blood pressure. The genes coding for each protein involved 
in the RAAS have been identified and studied for any relation with 
hypertension and other cardiovascular disorders (Malik et al., 1997).
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 Genetic polymorphisms involved in RAAS genes susceptibility 
to hypertension and T2DM have been intensively scrutinised by 
linkage and association studies in various populations. Insertion/
Deletion polymorphism of angiotensin-1 converting enzyme (ACE) 
gene, M235T, T174M, A20C and A6G variants in angiotensinogen 
(AGT) gene, BglI, MboI dimorphism in Renin (REN) gene, 
A1166C polymorphism of angiotensin II type1 receptor (AT1R), 
T344C, Lys173Arg variant in aldosterone synthase (CYP11B2) 
and the Gly460Trp polymorphism of adducin (ADD) gene have 
been implicated in the pathogenesis of hypertension, renal and 
cardiovascular complications of diabetes (Fabris et al., 2005). 
Genetic variants of RAAS genes are well studied in various 
populations with conflicting results.
Angiotensin Converting Enzyme Gene Polymorphism
Angiotensin Converting Enzyme gene is a major component in 
RAAS which has been determined as a candidate gene for the 
development of EHT (Agachan et al., 2003). The Framingham 
Heart Study found strong evidence for a QTL on chromosome 
17, located close to the ACE gene and linked to blood pressure 
(Levy et al., 2000). The ACE gene encodes somatic and germinal 
isoenzymes. The somatic ACE isoenzyme is expressed in many 
tissues including vascular endothelial cells, renal epithelial cells 
and testicular leidig cells, whereas the testicular or germinal 
ACE isoenzyme is expressed only in sperm. Tissue-bound ACE is 
essential for the control of BP and the structure and function of the 
kidneys (Lele et al., 2003).
 The ACE polymorphisms appear to have a significant impact on 
the progression of Hypertension and Diabetes (Figure 6). The ACE 
(dipeptidyl carboxypeptidase) is a zinc metallopeptidase, which 
catalyses the conversion of angiotensin I to angiotensin II, a potent 
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vasoconstrictor and through protease activity it also inactivates 
bradykinin, a potent vasodilator (Erdos and Skidgel, 1987). ACE 
gene has been mapped to chromosome17q23 and encoded by a 21 
Kb gene that consists of 26 exons and 25 introns (Mattei, et al., 
1989). 
 
Figure 6   Schematic diagram showing the biallelic polymorphisms 
numbered in base pairs relative to the start of the transcription sites 
between the exons 1-26 of ACE gene 
(Adapted from Keavney et al., 1998). 
Insertion/ Deletion Polymorphism of  ACE Gene
Insertion/Deletion (I/D) polymorphism of a 287 bp Alu repeat 
sequence in intron 16 of ACE gene is strongly associated with 
plasma and cellular ACE levels (Rigat et al.,1990) and it indicates 
that, the polymorphism may modulate the expression of ACE gene 
(Suehiro et al., 2004). Plasma ACE levels are affected mainly by this 
polymorphism and subjects that are homozygous for the deletion 
(DD), heterozygous (I/D) and those that are homozygous for the 
insertion (I/I) have the highest, intermediate and lowest ACE plasma 
levels, respectively (Rigat et al.,1990). 
 A relationship between the D-allele dose and enzymatic levels 
is established for both circulating and cellular ACE (Tiret et al., 
1992). The DD genotypes and D alleles of ACE gene have been 
reported in various populations in which it has a strong association 
❚❘❘ 30
Does Genetic Polymorphisms Affect Health?
with increased risk of hypertension (Zee et al.,1992) diabetes and 
its complications (Marre et al.,1994) compared to II genotypes 
and I allele of ACE gene. However, some studies have failed to 
show the association of D allele (Chiang et al., 1997) and diabetes 
(Daimon et al., 2003). A strong association of I allele of ACE gene 
is found in Australian population with familial hypertension (Zee 
et al., 1992). The conflicting results of I/D polymorphism of ACE 
gene in hypertension and other diseases might be due to different 
ethnic groups and genders (Barley et al., 1994).
Angiotensinogen Gene Polymorphisms
Angiotensinogen (AGT) is the precursor of angiotensin II, a 
polypeptide primarily produced by the liver which acts as a 
physiologically important regulator of blood pressure, exerting 
physiologic effects on the sodium homoeostasis, as well as a growth 
factor of cardiac myocytes. Gaillard et al, (1989) found that the 
human angiotensinogen gene contains 5 exons (Figure 7).  In 1992, 
Jeunemaitre et al, reported significant evidence for linkage and 
association of the (AGT) gene to hypertension.
 The AGT polymorphisms might not only be associated with 
plasma concentrations of AGT, but might also increase the eventual 
risk of developing hypertension. Several lines of evidence have 
supported the etiological link between AGT and hypertension; for 
example, in transgenic mice, the increasing number of AGT alleles 
was shown to be correlated with blood pressure elevation (Kim et 
al.,1995). An angiotensinogen M235T polymorphism has been 
found to be associated with high plasma AGT levels in subjects 
that are homozygous for the T variant and hence associated with 
hypertension in European and Asian populations (Danser et al., 
1998)
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 The TT or allele T of the M235T variant of the AGT is 
significantly associated with EHT in which it is a possible genetic 
marker or risk factor for hypertension in Malaysian subjects (Say 
et al.,2005). Rather than focusing on the M235T polymorphism 
in Malaysian population and to surpass the limitation of previous 
association studies, it looks for other susceptible polymorphism of 
the AGT gene for EHT and T2DM. The promoter polymorphisms 
A6G and A20C, which may play regulatory roles in the AGT gene 
expression, are suggested to be located in the same haplotype block 
with the M235T polymorphism (Hilgers, et al., 2001). Inoue et al., 
1997 revealed that the elevation of plasma angiotensinogen is not 
due to the M235T substitution itself but a linked A for G substitution 
at position -6 in the core promoter of the AGT gene. The A6G 
polymorphism affects the basal rate of AGT transcription with the 
-6A variant causing an increase in transcription and elevated plasma 
angiotensinogen levels is associated with hypertension (Hunt et al., 
1998).
    
 
Figure 7  Schematic diagram of the human Angiotensinogen gene and 
location of identified variants. The positions of the variants in the 5’ 
region are numbered by reference to the transcription-initiation site as 
defined by Gaillard et al, (1989).
 A6G, a common variant in the proximal promoter of the ATG 
gene, an adenine instead of a guanine 6 bp upstream from the site of 
transcription initiation, is in very tight linkage disequilibrium with 
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T235 and marks the original form of the gene. These observations 
suggested a biologic mechanism by which individual differences in 
the AGT gene may predispose carriers to the development of EHT
In addition, C for A substitution at position 20 polymorphism of 
the angiotensinogen gene core promoter that may cause altered 
gene transcription have been described: and elevated plasma 
angiotensinogen leads to increased angiotensinogen transcription 
in vitro. Evidence has been provided that this polymorphism affects 
transcription factor binding and the gene transcription rate (Zhao 
et al., 1999). The -20 C allele is associated with hypertension and 
elevated plasma angiotensinogen in a Japanese population (Ishigami 
et al., 1997). An adenine-to-cytosine transition at nucleotide -20 
of the 5’ upstream core promoter region of the human AGT gene 
(A-20C) mutation transcribes a reporter gene at a greater level 
than the wild type (A-20A). Therefore, the A-20C mutation may 
also affect the transcription activity of AGT mRNA in humans and 
thereby alter the plasma AGT level (Ishigami et al., 1997).
Aldosterone Gene Polymorphism
 
Aldosterone Synthase Gene Polymorphism
Aldosterone controls sodium balance and intravascular volume and 
plays an important role in regulating the blood pressure (White, 
1994). Aldosterone is synthesized from deoxycorticosterone in the 
zona golmerulosa of adrenal cortex by a mitochondrial cytochrome 
P450 enzyme, aldosterone synthase (CYP11B2) (Curnow et al., 
1991). The CYP11B2 gene encoding aldosterone synthase is 
mapped to chromosome 8q24.3 which is adjacent to a closely related 
gene that encodes steroid 11b-hydroxylase (CYP11B1), an enzyme 
required for cortisol biosynthesis (Mornet et al., 1989). 
 Conversely, an inherited form of hypertension, glucocorticoid-
suppressible hyperaldosteronism, is caused by genetic recombination 
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between the CYP11B1 and CYP11B2 that increase expression of 
the CYP11B2 and lead to inappropriate secretion of aldosterone 
(Lifton et al., 1992). Therefore, it is plausible that polymorphisms 
in CYP11B2 might affect aldosterone biosynthesis and thus perhaps 
influence hypertension.
 Mutations in the CYP11B2 lead to various forms of aldosterone 
deficiency, characterised by salt wasting and hypotension (Mitsuuchi 
et al., 1993) suggesting that abnormalities in CYP11B2 can lead to 
important changes to arterial pressure and could be responsible for 
hypertension. White and Slutsker, (1995) determined the haplotypes 
in CYP11B2 has strongly associated with hypertension or plasma 
aldosterone concentrations. 
 Davies, et al, (1999) have indicated the role of the T344C 
polymorphisms in aldosterone synthase gene in hypertension. 
But studies in Japanese and German populations showed the 
negative association of the T344C polymorphisms in association 
with hypertension (Kato et al., 2002).  However, it is impossible 
to conclude which polymorphism is responsible for high blood 
pressure or high aldosterone secretion. On the other hand, Fardella 
et al, 1996 indicated that Arg173 alleles are found higher in 
hypertensive than the normotensive group. They also found 
amino acid polymorphism showing Lys173 rather than Arg173 in 
CYP11B2 among a large number of Chilean patients with low-renin 
hypertension. The decreased frequencies of Arg173 and 2344C 
variants in the CYP11B2 gene are genetically linked to low-renin 
hypertension in the Japanese population.
Adducin Gene Polymorphism
Adducin, the rate-limiting factor in RAAS, plays a crucial role in the 
regulation of blood pressure. Adducin is a heteromeric cytoskeleton 
protein composed of α and ß-subunits. Variation in the α-adducin 
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(ADD1) protein may affect ion transport through modification 
of actin cytoskeleton assembly and modulation of sodium pump 
activity (Staessen and Bianchi, 2005). Transport of sodium by the 
renal proximal tubule determines whole-body volume and fluid 
homeostasis and blood pressure and it has been suggested that 
defects in transport mechanisms may be the cause of hypertension 
(Woolfson et al., 1996).
 Studies using Millan hypertensive and normotesnive strains of 
rats suggested that genetic alterations in tubular reabsorption may 
be a cause of hypertension (Bianchi et al.,1994). A case-control 
study in Milan of 190 white hypertensive patients using several 
microsatellite markers on chromosome 4 found a significant 
association with hypertension for one located closest (20 kb) to 
the α-adducin gene (Casari et al., 1995). Cusi et al., (1997) found 
a significant association between a Gly460Trp polymorphism 
(G460W) in the ADD1 gene and salt sensitivity in patients with 
EHT. Several studies have suggested that the association or linkage 
of G- to-T substitution polymorphism of amino acid residue 460 at 
nucleotide position 614 of exon 10 of the α-Adducin gene in EHT 
with controversial results in different populations.
 In Italian, French and Japanese population studies of the 
Gly460Trp polymorphism, a significant association of the mutated 
allele (Trp) with hypertension is shown (Castellano et al., 1998). All 
these data strongly supported the notion that Adducin polymorphism 
is associated to high blood pressure. Follow-up studies of different 
populations do not replicate the initial report whereby no association 
is found between the Gly460Trp allele and hypertension in Chinese 
(He et al., 2001), Scottish (Clark et al., 2000) or Japanese population 
(Ranade et al.,2000).
35 ❘❘❚ 
Patimah Ismail
Adrenoceptors
All adrenergic receptors have seven membrane-spanning domain, 
extra cellular amino terminal and intra cellular carboxy terminals. 
They are also linked to guanine-nucleotide- binding proteins (G 
proteins) which are composed of α, β and γ subunits (Garland & 
Biaggioni, 2001). The α-adrenoceptors mediate smooth muscle 
contraction, vasoconstriction, ejaculation and sodium excretion. The 
β-adrenoceptors mediate smooth muscle relaxation, vasodilatation, 
bronchial relaxation and lipolysis.
 Sympathetic nervous system plays an important role in the 
regulation of blood pressure and energy expenditure via coupling 
of catecholamine with adrenoceptors. (Masuo, 2010)
Polymorphisms of  β2-adrenoceptor 
The β2-adrenergic receptor has been well studied. Nine single 
nucleotide polymorphisms are found in the coding region of the 
DNA sequence. Four of these result in amino acid change: the 
glycine for arginine substitution at codon 16 (Arg16Gly), the 
glutamic acid for glutamine substitution at codon 27 (Gln27Glu), 
the threonine for isoleusine substitution at codon 164 (Thr164Ile) 
and the methionine for valine substitution at codon 34 (Val34Met). 
All these polymorphisms encode the receptor with functional 
differences except the Val34Met polymorphism. (Garland and 
Biaggioni, 2001). The most common polymorphisms are Arg16Gly 
with an allele frequency of 0.4/0.6 and Gln27Glu with an allele 
frequency of 0.55/0.45 in the Caucasian population. The Thre164Ile 
polymorphism is rare occurring in only 3 to 5 % of the general 
population. (Masuo, 2010).
 Beside the polymorphisms of the β2 adrenergic receptor in the 
coding region, there is also another polymorphism in the 5’ leader 
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citron of the receptor resulting in an arginine or cysteine of amino 
acid 19. This polymorphism with a frequency of approximately 0.47 
in whites, it can affect receptor expression. (Garland and Biaggioni, 
2001). Other studies showed that Gly16 receptors have greater 
reduction in number or enhanced down-regulation compared with 
Arg16 (wild type). On the other hand, Glu27 receptor is resistant 
to down-regulation when compared with Gln27 (wild type).
 The finding of the polymorphisms in the β2adrenergic receptor 
allows the researchers to correlate the polymorphism with diseases 
that involve of β2-adrenergic receptor activity such as hypertension. 
Studies have shown that the Gly16 homozygous subjects had higher 
mean blood pressure than Arg16 homozygous. They also found 
that Arg16 is associated with greater vasodilator response to β2 
agonist salbutamal compared with the Gly16 allele. (Garland and 
Biaggioni, 2001).
 Other studies with similar findings demonstrated that young 
normotensive white men homozygous for the Gly16 allele have 
higher blood pressure and lower peripheral vasodilatation after the 
administration of β2 agonist salbutamal ( Masuo, 2010). 
 Another longitudinal study done by Masuo et al.,, showed that 
Gly16 allele is related greater weight and blood pressure elevation 
over 5 years period. In this study 160 young, nonobese nomotensive 
individuals were recruited. Change in blood pressure, body weight, 
plasma noepinephrine and β-adrenergic receptor polymorphisms 
were measured over a period of 5 years. The result showed increase 
in body weight, blood pressure in Gly16 allele carriers. Subjects 
with Glu27 allele have higher blood pressure.
 From the results obtained in these studies, it can be said that 
the functional molecular variations of β2-adrenergic receptor 
might cause attenuated vasodilatation leading to increase in total 
peripheral resistance and consequently resulting in hypertension. 
(Kato et al., 2002)
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Polymorphisms of  β3-adrenoceptor
The β3 adrenergic receptor is mainly located in adipose tissue 
and it is involved in the regulation of lipolysis and thermogenesis. 
Due to the role of the receptor in the lipolysis, studies have been 
extensively done to correlate the receptor variant and obesity. A 
polymorphism in causing the substitution arginine for tryptophan 
at codon 64 (Try64Arg) has been well studied.  This polymorphism 
has been shown to lower receptor affinity for catecholamine and 
decrease receptor function. (Masuo, 2010). This slow lypolysis 
may lead to visceral obesity and obesity related diseases such as 
hypertension and diabetes mellitus. Other epidemiological studies 
have shown strong association between β3 adrenergic receptor 
polymorphism (Try64Arg), hypertension, metabolic syndrome and 
obesity. (Masuo, 2010)
Alpha-Adrenorecptor Gene Polymorphism
Catecholamines play an important role in the regulation of blood 
pressure and metabolism in humans (Gavras et al., 2001). There 
are three known α2-adrenoceptor subtypes, α2A, α2B, and α2C, 
which are encoded by distinct genes at different chromosomes. 
Knockout animal studies have suggested that sympathetic outflow 
from the central nervous system is inhibited by stimulation of the 
α2A-adrenergic receptor, thus mediating a hypotensive effect, 
whereas stimulation of the α2B -adrenergic receptor mediates a 
hypertensive effect by opposing the sympatho-inhibitory action 
of the α2A-adrenergic receptor in the central nervous system. The 
α2C-adrenergic receptor does not seem to mediate any effect in 
blood pressure regulation (Gavras et al., 2001).
  A polymorphism in the non-coding region of the α2A-
adrenoceptor gene has been reported to be associated with salt-
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sensitive hypertension in an African-American population (Lockette 
et al., 1995). But a common variant (12Glu9) of the human α2B-
adrenergic gene encodes a receptor protein leading to the deletion/
insertion of three consecutive glutamate residues at amino acid 
positions 301 to 303 has been associated with EHT (Wowern et 
al.,2004) and acute coronary events (Snapir et al.,2001). Several 
studies suggested that I/D polymorphism of α2B-adrenergic 
receptor gene control the sympathetic nervous system activity and 
possibility to develop EHT (Wowern et al., 2004).  
 In a population-based, prospective study on 912 middle- aged 
men, the DD genotype is associated with an increased incidence 
of acute myocardial infarction (AMI) in comparison to the other 
two genotypes (Snapir et al.,2003). Several reports in Caucasians 
revealed the association of various cardiovascular and metabolic 
phenotypes with I/D polymorphism of α2B-adrenergic receptor 
gene (Heinonen et al., 1999). However some reports do not support 
a role for I/D polymorphism of α2B-adrenergic receptor gene in late 
complications in type 1 diabetic patients (Heinonen et al., 2005) 
and EHT (Snapir et al., 2001). 
CANDIDATE GENES FOR CONGENITAL HEART DISEASE
Homocysteine Metabolism Enzyme Gene Polymorphisms and 
Congenital Heart Disease
Congenital heart disease (CHD) is known as a serious birth 
defect where there is an abnormal development of the structure 
and function of the heart that are present at birth. It is among the 
most common human congenital defects occurring in 6-8 out of 
1000 live births (Hoffman et al., 2002). There are many factors 
causing the CHD etiology whereas both genetic and environmental 
factors also play an important role in the etiology, but the specific 
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cause still remains unclear (Song et al., 2006). Homocysteine is a 
naturally occurring amino acid that is present in the humans. It is 
involved in the metabolism of the essential amino acid methionine 
which is a product used in transmethylation reactions that utilise 
S-adenosylmethonine (AdoMet) as a methyl donor. After being 
formed, homocysteine can be catabolised to amino acid cysteine 
or it can be used to regenerate AdoMet (Kluijtmans et al., 2003). 
 Hyperhomocysteinemia is an elevated level of homocysteine 
in the blood and some of the factors that cause this could be due 
to genetic disorders, vitamin B12 and vitamin B6 deficiency, folic 
acid deficiency, renal failure, increasing age, hypothyroidism 
and smoking (Pereira et al., 2005). This condition has also been 
associated with the development of CHD and many genetic 
association studies have been done to investigate this association. 
 A few types of CHD are induced by single gene mutation 
and chromosome aberration but most of CHDs are polygenic 
diseases caused by both genetic and environmental factors (Zhu 
et al., 2004). The common enzymes involved in homocysteine or 
folate metabolism are the Methylenetetrahydrofolate Reductase 
(MTHFR), Methionine Synthase (MTRR), Methionine Synthase 
Reductase (MTR) and Cystathionine-b-synthase (CBS) enzymes. 
Deficiencies or polymorphism in any of these enzymes are suspected 
to lead to an inborn error in the metabolism of homocysteine and 
also causing homocystinuria (Michael et al., 2000). There is 
evidence that this deficiency could alter the susceptibility to CHD 
(Garcia-Fragoso et al., 2010). 
 Various studies have been done in various populations on the 
association of these enzyme gene polymorphisms and development 
of CHD but with conflicting results. This may be due to the 
differences between ethnic or geographic populations. Population 
stratification which is the separation of a study population into 
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subgroups may also occur if the case and control populations are 
not well matched for ethnicity or geographic origin.
 For the MTHFR enzyme, it is one of the main regulatory 
enzymes of the homocysteine metabolic pathway and it involves 
the two most common gene polymorphism which are the C677T 
and the A1298C (Frosst et al., 1995). These polymorphisms may 
result in decreased enzyme activity and causes increased level of 
homocysteine in individuals especially those with low folate status 
(Castro et al., 2003). A study done in Germany by Junker et al, 2001 
was the first study that showed an association between C677T gene 
polymorphism and the development of CHD. Other studies done for 
the MTHFR gene polymorphism can also be found in Puerto Rico 
and India (Elavazhagan et al, 2009, Garcia-Fragoso et al., 2010).
 A study done in Beijing, China showed a nuclear family study 
on the association of the MTR enzyme of the A2756G gene 
polymorphism and CHD. They have found that mothers having the 
polymorphism may have an increase risk of having a child born 
with CHD (Zhu et al., 2004). For the MTRR A66G enzyme gene 
polymorphism, a study done in The Netherlands investigated the 
relation between this polymorphism and CHD risk (Van Beynum 
et al., 2006).
 Michael et al, 2006 reported a high prevalence of the 844ins68 
gene polymorphism of the CBS enzyme. Since CBS enzyme is 
also involve in the homocysteine metabolic pathway, researchers 
suggested that it may also be related to development or risk of CHD. 
Various studies have also been done to investigate this relationship. 
For example a study done by Zhu et al.,2008 found an association 
between the CBS gene variation and serum homocysteine level 
associated with CHD and  a Chinese nuclear family study  by Song 
et al.,2006 showed that there is also a relationship between the CBS 
polymorphism and CHD. 
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 A genetic association analysis involving a study of the SNPs 
genotype frequency in a group of cases and controls could be used to 
examine the statistical correlation between a person’s genotype with 
his phenotype or disease. So, by this, the genetic polymorphisms of 
the homocysteine metabolism genes can provide a basic for studying 
the relationship between genetic variants and the development or 
progression of CHD.
Cardiac Transcription Factors Gene Polymorphism
Members of cardiac transcription factors genes family codes for 
proteins (transcription factors) that regulate the expression of genes 
responsible for embryonic cardiac development which include the 
formation of the heart chambers (atria and ventricles), valves and 
the conducting system. Because of this critical role, mutations 
within these genes will affect the gene expression which in turn 
will contribute to the pathogenesis of the malformed heart (Clark 
et al., 2006). Among the transcription factors gene family there is 
four genes: GATA4, TBX5, TBX20 and NKX2-5 that had been 
implicated more in the cause of CHD. 
GATA4 Gene Polymorphism
GATA4 gene is a one of the transcription factors genes that 
localised at chromosome 8p23.1-p22. The gene consists of 7 exons 
and  contains two zinc finger domains that  are highly conserved 
in mammals. It expresses in the heart during embryogenesis and 
plays a major role in the process of the heart development (Clark 
et al.,2006). The GAtA4 gene regulates the expression of MYH6 
gene which play an important function in the development of the 
cardiac atria (Molkentin and Kalvakolanu 1994).It has 2 zinc finger 
domains: C-terminal and N-terminal domains, the C-terminal 
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domain encoded by exon 2, mediates DNA binding and interaction 
with other proteins including Nkx2-5 and TBX5 (other transcription 
factors)while  the N-terminal domain encoded by exon 3, help in 
stabilising the binding to DNA and interacting with a subclass of 
zinc finger protein multi-type (ZFPM) previously named  friend of 
GATA4 (FOG) ( Clark et al.,2006).
TBX20 Gene Polymorphism
TBX20 is an ancient member of the Tbox superfamily related to 
TBX1,located on chromosome 7p15-p14, it contains 6 exons and its 
22 kb size, code for 297-amino acid protein (Meins et al.,2000)and 
interact with GATA4,GATA5, TBX5 and NKX2-5 genes (Stennard 
et al.,2003).  
 The first report of the association between TBX20 and CHD 
done by (Kirk et al.,2007) by screen the coding region of TBX20 
by direct sequencing in 352 patients with different forms of CHD 
and 11% of those patients have a family history of CHD, two unique 
mutations  are reported missense I152M (456C>G) and nonsense 
Q195X (583C>T) mutations within the T-box DNA-binding domain 
TBX20 in two Caucasian families with  history of various forms of 
CHD (septation defects, valve abnormalities (mitral valve stenosis 
and prolapse)  in addition to cardiomyopathy.  Analysis of these 
mutated protein showed direct effects of this mutation on the protein 
structure, its thermal stability, and DNA binding.
 A study conducted by (Liu et al.,2008) to determine the TBX20 
mutations in Han Chinese population and whether there is an 
association of these mutations with CHD, involved 203 patients 
with various forms of CHD (62 of them are TOF patients) and 
300 control were also involved in this study in which only 6 
patients had family history of CHD, the exons  2-6 which coded 
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for T-box domain and their flanking introns were sequenced after 
PCR amplification, Three non-synonymous sequence alternation 
(A63T, I121F, and T262M) were identified in 3 patients (two ASD 
patients one of them had an additional Total anomalous pulmonary 
venous connection  and one  TOF patient) which were not seen in 
300 controls, I121F and T262M mutations occurred within the 
highly conserved T-box DNA-binding domain and the change in 
the amino acid was expected  to affect protein function according 
to SIFT program (Sorting Intolerant From Tolerant), in addition 
to two synonymous sequence variants(c.666C>T and c.786G>C) 
detected only in two patients and not detected in the control and 
eight SNPs detected both on the patients and controls but the 
difference in the allele frequency between the patients and controls 
was statistically insignificant, four of them reported for the first 
time (S167S, P177P, A181A, and I219I)  and the other four were 
known SNPs in dbSNP (c.766T>C as rs3999941, c.808C>T as 
rs3864455, c.859C>T as rs2723753 and c.883A>C as rs2723754). 
The frequency of TBX20 mutations in the CHD patients was about 
1.5% and in TOF patients was about 1.6% (one of 62 ) so TBx20 
mutations in Chinese population were low and contributed to ASD, 
TOF and Total anomalous pulmonary venous connection (Liu et 
al.,2008)
Endothelial Nitric Oxide Synthase Gene Polymorphism
Nitric oxide, which plays important role  in the regulation of cell 
growth and apoptosis, is produced by the enzyme Endothelial nitric 
oxide synthase (eNOS)  Common 894G>T in the gene code for 
eNOS associated with birth defects such as spina bifida, and its 
association with CHD have been investigated  both in the affected 
children  and their mothers, an association of the sum of  the eNOS 
❚❘❘ 44
Does Genetic Polymorphisms Affect Health?
894 GT and TT genotypes versus GG genotypes in the children is 
associated with increased CHD risk, while in the mothers the sum 
of  eNOS 894 GT or TT genotypes  versus GG genotypes is not 
associated with increased CHD risk (Van Beynum et al.,2008).
TECHNIQUE TO DETECT SINGLE NUCLEOTIDE 
POLYMORPHISM
PCR- Restriction Fragment Length Polymorphism (PCR-
RFLP)
A variation in the DNA sequence result either in polymorphism 
or mutation which leads to chances of causing different diseases. 
Some of these polymorphisms that occur with a high frequency 
within the population can be a useful tool for gene tracking for 
a given disease. Such investigations have initially been done 
by Southern blot techniques, but now it has been replaced by 
PCR based methodology. By using restriction enzyme analysis 
or Restriction Fragment Length Polymorphisms (RFLPs), the 
nucleotide substitutions can be identified (Figure 8). Currently, 
SNP typing is becoming more and more popular in genetic research 
and some typing methods have been developed with many other 
methods, such as Taqman assay, the ligase detection reaction and 
D-HPLC (Kirk et al., 2002), developed in recent years but still 
RFLP-PCR is relatively simple and economical (Haliassos et al., 
1989). A restriction fragment length polymorphism is defined by the 
existence of alternative alleles associated with restriction fragments 
that differ in size from each other. The basic principle of RFLP is the 
DNA restriction enzymes recognise specific sequences in DNA and 
catalyse endonucleolytic cleavages, yielding fragments of defined 
lengths. Differences among individuals in the lengths of a particular 
restriction fragment may be displayed by electrophoresis in agarose 
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gels, separating the fragments according to their molecular size. The 
results from many kinds of genotypic differences shows one or more 
individual bases could differ, resulting in loss of a cleavage site or 
formation of a new one; alternatively, insertion or deletion of blocks 
of DNA within a fragment could alter its size. These genotypic 
changes can be recognised by the altered mobility of restriction 
fragments on agarose gel electrophoresis (Botstein et al., 1980). 
 Figure 8  Schematic diagram shows the principle involved in PCR-
RFLP method (Adapted from Human Molecular Genetics, 2004)
 RFLPs were first used as a tool for genetic analysis in 1974. 
Linkage of temperature-sensitive mutations of adenovirus to 
specific restriction fragment length differences was used to locate 
the mutations on a physical map of the restriction fragments 
(Grodzicker et al., 1974). Although RFLP is a useful technique 
in finding out the known mutations, it has got several limitations, 
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including the fact that the flanking regions of most SNP loci do 
not have appropriate restriction endonuclease recognizing site 
for typing and cannot able to detect the unknown mutations. The 
main advantage of this approach is that it does not require the use 
of radioactive isotopes and it is more acquiescent to analyses in 
clinical settings.
Restriction Enzymes 
Restriction endonucleases (REs) are present in bacteria presumably 
to destroy DNA from foreign sources (e.g., infecting bacteriophage) 
by cleaving the foreign DNA at specific restriction sites The 
host bacteria DNA is protected from cleavage because specific 
recognition sites are modified, usually by methylation at one of 
the bases in the site, making the site no longer a substrate for 
RE cleavage. Host bacteria used to propagate cloned DNA in the 
laboratory are usually mutant in the host restriction genes; thus 
their intracellular enzyme activities will not destroy the foreign 
recombinant sequences. The cleavage site specifities for many 
REs have been defined. They cut DNA within or near to their 
particular recognition sequences, which typically are four to six 
nucleotides in length with a twofold axis of symmetry. These ends 
are complementary (“sticky”) and can be enzymatically reattached 
to any other EcoRI generated termini using T4 DNA ligase. Many 
restriction enzymes, like EcoRI, generate fragments with protruding 
5’ tails; others (e.g., PstI) generate fragments with 3’ protruding, 
cohesive termini, whereas still others (e.g., BalI) cleave at the axis 
of symmetry to produce blunt-ended fragments. Each restriction 
endonuclease has a specific sequence and number of nucleotides 
required to create the recognition site. Some REs do not require 
a specific nucleotide in every position of the recognition site. 
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These enzymes allow cloning and purification as well as for RFLP 
technique. REs are typically isolated from a variety of bacterial 
strains and available commercially (Roberts, 1982). 
Agarose Gel Electrophoresis 
Electrophoresis is a technique used to separate and sometimes purify 
macromolecules - especially proteins and nucleic acids - that differ 
in size, charge or conformation. Amplified PCR products, restriction 
fragments and other products can be identified or separated by using 
the standard method through agarose gel electrophoresis. Molecules 
in a mixture can be separated according to size by electrophoresis, 
a technique dependent on the fact that dissolved molecules in an 
electric field move at a speed determined by their charge-mass ratio. 
The basic principle behind in this technique is the nucleic acids in 
solution generally have a negative charge because of the presence of 
phosphate groups are ionized; thus they migrate toward a positive 
electrode.  Molecules separated into the electrophoresis in an 
agarose gel move through the pores, the longer length nucleic acids 
moves slowly compared to the shorter length sequences. Agarose gel 
electrophoresis technique is simple, rapid to perform, and capable 
of resolving mixtures of DNA fragment that cannot be separated 
adequately by other sizing procedures (Sambrook, 2001). Agarose, 
which is extracted from seaweed, is a linear polymer is commercially 
available in the market. Agarose is usually contaminated with 
other polysaccharides, salts, and proteins which can affect both the 
migration of the DNA and the ability of the DNA recovered from 
the gel to serve as a substrate to enzymatic reactions. Agarose gels 
are cast by melting the agarose in the presence of the desired buffer 
until a clear, transparent solution is achieved. The melted solution 
is then poured into a mold and allowed to harden. Upon hardening, 
the agarose forms a matrix, the density of which is determined by 
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its concentration. When an electric field is applied across the gel, 
DNA, which is negatively charged at neutral pH, migrates toward 
the anode.  Furthermore, the location of DNA within the gel can 
be determined directly by staining the gel with the intercalating 
dye ethidium bromide and can be detected by direct examination 
of the gel in ultraviolet light (Sharp et al., 1973).
GENETIC POLYMORPHIC STUDIES IN MALAYSIA- 
RESEARCH PAPERS FROM GENETIC RESEARCH GROUP
Hypertension and Type 2 Diabetes Mellitus
Analysis of renin-angiotensin aldosterone system gene 
polymorphisms in Malaysian essential hypertensive and type 
2 diabetic subjects
Vasudevan Ramachandran, Patimah Ismail, Johnson Stanslas and 
Norashikin Shamsudin
Cardiovascular Diabetology 2009, 8:11
The renin-angiotensin aldosterone system (RAAS) plays an 
important role in regulating the blood pressure and the genetic 
polymorphisms of RAAS genes has been extensively studied in 
relation to the cardiovascular diseases in various populations with 
conflicting results. The aim of this study was to determine the 
association of five genetic polymorphisms (A6G and A20C of 
angiotensinogen (AGT), MboI of renin, Gly460Trp of aldosterone 
synthase and Lys173Arg of adducin) of RAAS genes in Malaysian 
essential hypertensive and type 2 diabetic subjects. RAAS gene 
polymorphisms were determined using mutagenically separated 
PCR and PCR-RFLP method in a total of 270 subjects consisting 
of 70 hypertensive subjects without type 2 diabetes mellitus 
(T2DM), 60 T2DM, 65 hypertensive subjects with T2DM and 75 
control subjects.  There was significant difference found in age, 
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body mass index, systolic/diastolic blood pressure, fasting plasma 
glucose and high density lipoprotein cholesterol levels between the 
hypertensive subjects with or without T2DM and control subjects. 
No statistically significant differences between groups were found 
in the allele frequency and genotype distribution for A20C variant 
of AGT gene, MboI of renin, Gly460Trp of aldosterone and 
Lys173Arg of adducin (p > 0.05). However, the results for A6G of 
AGT gene revealed significant differences in allele and genotype 
frequencies in essential hypertension with or without T2DM (p < 
0.001). Among the five polymorphisms of RAAS genes only A6G 
variant of AGT gene was significantly associated in Malaysian 
essential hypertensive and type 2 diabetic subjects. Therefore, 
A6G polymorphism of the AGT gene could be a potential genetic 
marker for increased susceptibility to essential hypertension with 
or without T2DMin Malaysian subjects
Association of insertion/deletion polymorphism of 
angiotensin-converting enzyme gene with essential 
hypertension and type 2 diabetes mellitus in Malaysian 
subjects
Vasudevan Ramachandran, Patimah Ismail, Johnson Stanslas, Norashikin 
Shamsudin, Saidi Moin, Rusni Mohd Jas
J Renin Angiotensin Aldosterone Syst 2008; 9; 208
The deletion (D) allele of the angiotensin-converting enzyme 
(ACE) gene has been studied in various populations in relation to 
hypertension (HTN) and type 2 diabetes mellitus (T2DM) with 
contradictory results. This study sought to determine the association 
of insertion (I)/D polymorphism of the ACE gene in hypertensive 
and T2DM subjects in a Malaysian population.  A total of 260 
subjects consisting of 65 HTN, 60 T2DM, 65 T2DM with HTN 
and 70 controls were recruited. Genotyping was performed by 
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polymerase chain reaction initially and mistyping of DD genotypes 
was performed with an insertion-specific primer. The frequency for 
II, ID and DD genotypes of the ACE gene was 36.92%, 52.31% and 
10.77% in HTN, 40.00%, 41.67% and 18.33% in T2DM, 30.77%, 
53.85% and 15.38% in T2DM with HTN and 57.14%, 40.00% and 
2.86% in controls, respectively. The frequency for the D allele was 
36.92% in HTN, 39.17% in T2DM and 42.31% in T2DM with HTN 
compared to 22.86% in controls. The genotype and allele frequency 
of the ACE gene polymorphism differed significantly in patients 
when compared to controls (p < 0.05). The D allele of the ACE gene 
is associated with essential HTN and T2DM in Malaysian subjects.
Association of Insertion/Deletion Polymorphism of Alpha-
Adrenoceptor Gene in Essential Hypertension with or 
without Type 2 Diabetes Mellitus in Malaysian Subjects
R. Vasudevan, Patimah Ismail, Johnson Stanslas, Norashikin Shamsudin, 
Aisyah binti Ali
Int. J. Biol. Sci. 2008, 4
An insertion/deletion (I/D) polymorphism of Alpha2B-Adrenoceptor 
(ADRA2B) gene located on chromosome 2 has been studied 
extensively in related to cardiovascular diseases. The main aim of 
the present study was to examine the potential association of D allele 
frequency of I/D polymorphism of ADRA2B gene in Malaysian 
essential hypertensive subjects with or without type 2 diabetes 
mellitus (T2DM). This study included 70 hypertensive subjects 
without T2DM, 65 hypertensive subjects with T2DM and 75 healthy 
volunteers as control subjects. Genotyping of I/D polymorphism 
was performed by conventional PCR method. There was significant 
difference found in age, body mass index, systolic/diastolic blood 
pressure and high density lipoprotein cholesterol level between 
the case and control subjects. DD genotypic frequency of I/D 
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polymorphism was significantly higher in hypertensive subjects 
(42.84% vs. 29.33%; P=0.029) and in hypertensive with T2DM 
subjects (46.15% vs. 29.33%; P=0.046) than control group. D allele 
frequency was higher in hypertensive group (67.41%) than control 
subjects (52.67%). However, no significant difference was found 
between the three genotypes of I/D polymorphism of ADRA2B 
gene and the clinical characteristics of the subjects. The result 
obtained in this study showed that D allele of ADRA2B gene was 
associated with essential hypertension with or without T2DM in 
Malaysian subjects.
Analysis of three genetic polymorphisms in Malaysian 
essential hypertensive and type 2 diabetic subjects
R. Vasudevan, Patimah Ismail1, Johnson Stanslas and Norashikin 
Shamsudin                          
African Journal of Biotechnology Vol. 8 (10), pp. 2069-2075, 18 May, 
2009
Genetic polymorphisms are associated with an increase in the risk 
of developing disease and they are integral to the development of 
genetic marker to identify the individuals at risk. The genotypic 
distribution of various genetic polymorphisms involved in essential 
hypertension (EHT) and type 2 diabetes mellitus (T2DM) in 
Malaysian subjects has not been well characterised. The main 
objective of this study is to determine the association of S477X 
polymorphism of LPL gene, A6244G polymorphism of IRS-1 gene 
and C825T polymorphism of GNB3 gene with EHT and T2DM 
in Malaysian subjects. This study included 70 EHT, 60 T2DM, 65 
EHT with T2DM and 75 control subjects. Genotyping of all the 
three polymorphisms was performed by PCR-RFLP method with 
the respective primers and restriction enzymes. The genotypic 
and allelic frequencies of the respective polymorphisms of the 
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genes did not differ significantly (p>0.05) with EHT and T2DM 
in Malaysian subjects. The results of this study suggested that, 
S477X genotypes of LPL gene, A6244G genotypes of IRS-1 gene 
and C825T genotypes of GNB3 gene was not associated with EHT 
and T2DM in Malaysian subjects.
End Stage Renal Disease
Analysis of insertion/deletion polymorphisms of the angiotensin 
converting enzyme gene in Malaysian end-stage renal disease 
patients
Aisyah Ali, Ramachandran Vasudevan, Patimah Ismail, Christoper Lim 
Thiam Seong and Srikumar Chakravarthi
 Journal of the Renin-Angiotensin-Aldosterone System Vol. 12, Issue 3, 
Sept 2011 pp 224-230
Insertion/deletion (I/D) polymorphisms found in the angiotensin 
converting enzyme (ACE) gene have been associated with 
hypertension, diabetes and renal disease. The present study sought 
to determine the association of I/D polymorphisms of the ACE gene 
with end-stage renal disease (ESRD) patients in Malaysia. A total 
of 380 subjects were recruited to determine the genotypes of I/D 
polymorphisms of the ACE gene. Genotyping was performed using 
a PCR method. Statistical analyses were carried out using statistical 
software, and a level of p < 0.05 was considered statistically 
significant. The frequencies for II, ID and DD genotypes of the 
ACE gene were 24.7%, 65.80% and 9.47%, respectively, in ESRD 
patients, and in control subjects were 45.26%, 47.37% and 7.37% 
respectively. The frequency for the D allele was found to be higher 
(42.40%) in ESRD patients compared to control subjects (31.05%). 
The genotypic and allelic frequencies of I/D polymorphisms of the 
ACE gene differed significantly (p < 0.05) between ESRD patients 
and control subjects in the Malaysian population. The findings of 
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this study indicated that I/D polymorphisms of the ACE gene are 
a useful marker and are likely to play a major role in determining 
genetic susceptibility to ESRD in the Malaysian population.
Association of variable number of tandem repeats polymorphism 
in the IL-4 gene with end-stage renal disease in Malaysian 
patients                                                                       
R. Vasudevan, M.N. Norhasniza and I. Patimah                                                                           
Genet. Mol. Res. 10 (2): 943-947 (2011)
Variable number of tandem repeats (VNTR) polymorphism in the 
interleukin 4 (IL-4) genes has been associated with end-stage renal 
disease (ESRD) subjects in many different populations, although 
with conflicting results. We determined the 70 bp of VNTR 
polymorphism at intron 3 of the IL-4 gene in Malaysian ESRD 
subjects. Buccal cells were collected from 160 case and 160 control 
subjects; genomic DNA was amplified using PCR, followed by 
agarose gel electrophoresis. There were significant differences in 
genotypes and alleles of the IL-4 gene. We concluded that VNTR 
polymorphism of the IL-4 gene is a risk factor for the development 
of ESRD among Malaysians.
 Malaysia is a multi racial country consisting of Malays, Chinese, 
Indians and the indigenous people of Sabah and Sarawak. Malays 
and other indigenous are found to have a higher prevalence of 
hypertension compared to the Chinese and Indians, but the Indians 
have more prevalence in T2DM compared to Malays and Chinese 
whereby the difference is not significant among the different ethnic 
groups (Lim et al., 2004).  Based on the candidate gene approach, 
many case-control and the cross-sectional studies have been done 
in Malaysia in predisposition to various diseases. Say et al., 2004 
showed a significant difference between the M235T variant of 
angiotensinogen gene and hypertension. But the same variant in a 
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recent study showed a lack of association in Malay hypertensive 
subjects (Ghazali et. al., 2008). This proves that, the genetic 
variation differs within the same ethnic or different groups due to 
various environmental factors (Persu et al., 2006).
 A cross-sectional comparative study showed no association in 
A1166C polymorphism of angiotensin II type I receptor gene with 
BP and aortic pulse wave velocity among the Malays (Rehman et 
al., 2007). A possible involvement of genetic polymorphism of 
CYP2D6 in patients with cardiovascular disease can be observed 
in a cohort study in Malaysia. 
FUTURE DIRECTIONS
The clinical potential of the SNP revolution has yet to be realised. It 
remains to be determined whether the current approaches, namely 
candidate gene studies and whole-genome scans, will be effective 
in dissecting the genetic basis of common as well as rare complex 
diseases. So far, the majority of published studies have identified a 
handful of genetic markers (i.e. SNPs) that alter the risk for disease 
outcome. It is difficult to predict how many genetic markers are 
validated in well-designed confirmation studies. If the current 
approaches are successful, the next step will be to understand the 
relationship among informative SNPs and haplotypes and begin to 
build profiles comprising genetic markers present in different regions 
of the genome. If this can be accomplished, an additional, difficult 
step will be to determine the significance of each contributing SNP 
or haplotype. In the near future, it will be necessary to develop more 
sophisticated analytical tools to investigate gene–gene interactions, 
but on a scale larger than currently available. Similarly, it will also 
be critical to account for gene–environment interactions, many of 
which will require parallel investigation in animal models or in 
vitro laboratory studies.
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 Deciphering the contribution of genetic variation to disease 
outcome carries important implications for the theory and practice 
of medicine. Based upon the initial findings of such investigations, 
it is anticipated that the most significant observations derived 
from SNP-based studies will be to identify genetic markers that 
alter the risk for a disease outcome. The intercalation of these 
data into clinical medicine will be a daunting task, because it will 
require substantial shifts in the public’s perceptions of genetic risk 
factors and the establishment of a new set of paradigms for clinical 
medicine. Currently, genetic testing is restricted mainly to a set 
of informative, highly penetrant disease conditions, in which the 
presence of a genetic mutation is predictive of a defined outcome. 
The exact manner in which the findings of SNP-based studies will 
be integrated into clinical practice remains to be defined. Most 
likely, it will impact preventive and early intervention strategies, 
encouraging individuals to make smart choices with respect to 
exposures or participation in high-risk activities.
 The promise of pharmacogenomics could substantially shift 
current algorithms for drug therapy in clinical medicine. Selection 
of a particular drug could take into account an individual’s genetic 
profile to predict the likelihood for response. Determination of 
genetic profiles associated with severe or life-threatening toxicity 
will permit health care providers to choose alternative prescriptions. 
An informative example is the altered metabolism of a commonly 
used drug for treatment of childhood acute lymphoblastic leukemia, 
6-mercaptopurine, which has a frequency of slightly less than 
1%. Previously, it has been noted that a small subset of patients 
developed potentially fatal hematopoietic toxicity. This low-
prevalence thiopurine intolerance occurs in individuals who are 
homozygous for one of several rare variants in the TPMT (thiopurine 
S-methyltransferase) gene27. These data suggested that screening 
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of newly diagnosed patients could avoid deleterious complications 
in all and thus, therapy could be modified for the at-risk group.
CONCLUSIONS
Thus, genetic polymorphisms do affect the health of an individual 
and do not directly cause the diseases but merely alter the risk of 
developing a disease.  By analyzing the disease associated SNPs we 
may predict the likelihood that an individual will develop a specific 
disease or physiological condition and can be used to develop 
clinical prevention.  Knowledge about the relationships between 
polymorphisms and disease outcomes and conducting the molecular 
epidemiological studies to detect the genetic polymorphisms can 
also be used for reinforcing healthy lifestyles, drug development, 
animal toxicity studies, improvement of human clinical trials, post 
market monitoring surveillance for drug efficacy and toxicity, 
motivating positive behavior changes, helping to target medical 
therapy, and aiding in better focusing surveillance activities.
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